BMEA Biomea Fusion, Inc.
Healthcare$1.42+3.65%ClosedMarket Cap: $84.5M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
5.48
P/S
0.00
EV/EBITDA
-0.65
DCF Value
$0.98
FCF Yield
-66.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-196.7%
ROA
-96.9%
ROIC
-173.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-12.8M | $-12.4M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-11.7M | $4.6M | $— | — |
| FY null | $0.00 | -Infinity% | $-81.3M | $-61.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-20.8M | $-16.4M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-21.3M | $-20.7M | $— | — |
| Q1 null | $0.00 | NaN% | $-29.7M | $-29.3M | $— | — |
| Q4 null | $0.00 | NaN% | $-30.1M | $-29.3M | $— | — |
| FY null | $0.00 | NaN% | $-144.1M | $-138.4M | $— | — |
| Q3 null | $0.00 | NaN% | $-34.0M | $-32.8M | $— | — |
| Q2 null | $0.00 | NaN% | $-38.9M | $-37.3M | $— | — |
| Q1 null | $0.00 | NaN% | $-41.1M | $-39.1M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-37.3M | $-34.9M | $-0.98 | — |